NCT01745549View on ClinicalTrials.gov

Efficacy, Safety and Satisfaction of the New Pen Needle 33 Gauge x 4 mm.

NACompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

November 30, 2013

Conditions
Type 1 DiabetesType 2 Diabetes
Interventions
DEVICE

Needle for insulin pen, 4 mm long and with a diameter of 33 gauge

DEVICE

Needle for insulin pen, 4 mm long and with a diameter of 32 gauge

Trial Locations (4)

22066

U.O.S. Diabetologia e Malattie Metaboliche - PO Cantù - Mariano Comense, Mariano Comense

24047

UO Malattie Metaboliche e Diabetologia - Ospedale di Treviglio-Caravaggio, Treviglio

25123

UO Diabetologia per Trattamento e Educazione dei Diabetici - Spedali Civili di Brescia, Brescia

00157

Struttura Complessa Dietologia-Diabetologia Malattie Metaboliche - Ospedale Pertini, Roma

All Listed Sponsors
collaborator

Artsana SpA

UNKNOWN

lead

Consorzio Mario Negri Sud

OTHER

NCT01745549 - Efficacy, Safety and Satisfaction of the New Pen Needle 33 Gauge x 4 mm. | Biotech Hunter | Biotech Hunter